InnoCare Pharma Limited (OTCMKTS:INCPF – Get Free Report) was the target of a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 1,397,382 shares, a growth of 294.9% from the January 29th total of 353,819 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ? days. Based on an average daily volume of 0 shares, the short-interest ratio is currently ? days.
InnoCare Pharma Stock Performance
OTCMKTS:INCPF remained flat at $1.55 during mid-day trading on Friday. InnoCare Pharma has a 52 week low of $1.55 and a 52 week high of $2.31. The firm’s 50 day moving average price is $2.00 and its 200-day moving average price is $2.57.
About InnoCare Pharma
InnoCare Pharma Ltd is a China-based, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule targeted therapies for oncology. Headquartered in Shenzhen, Guangdong Province, the company leverages structure-based drug design and comprehensive preclinical screening to advance drug candidates that address high-unmet-need cancers.
The company’s development pipeline comprises multiple small-molecule inhibitors in various stages of preclinical and early clinical evaluation.
Featured Articles
- Five stocks we like better than InnoCare Pharma
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for InnoCare Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnoCare Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
